...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >No evidence of association between NOD2/CARD15 gene polymorphism and atherosclerotic events after renal transplantation.
【24h】

No evidence of association between NOD2/CARD15 gene polymorphism and atherosclerotic events after renal transplantation.

机译:没有证据表明肾脏移植后NOD2 / CARD15基因多态性与动脉粥样硬化事件相关。

获取原文
获取原文并翻译 | 示例

摘要

Stable renal transplant recipients (RTR) display high rates of atherosclerotic events (AE). Innate immunity and especially vascular inflammation play a role in the pathogenesis of atherosclerosis. It is illustrated both by an increased occurrence of postrenal transplant cardiovascular events in patients with elevated levels of C-reactive protein and by a correlation between posttransplant AE and Toll-like receptor-4 Asp299Gly polymorphism. Here, we analyze the influence NOD2/CARD15 gene polymorphism since NOD2 can modulate macrophage pro-inflammatory activity and macrophage is present in early atherosclerotic lesions. The incidence of single nucleotide polymorphism (SNP) in the three major polymorphic region of NOD2 gene (SNP8, SNP12 and SNP13) was assessed in 182 RTR and the correlation between such polymorphism and the development of AE was analyzed. No correlation was observed between NOD2 gene polymorphism and the occurrence of AE after renal transplantation. NOD2 gene polymorphism thus does not appear to influence cardiovascular complications in RTR.
机译:稳定的肾移植受者(RTR)表现出较高的动脉粥样硬化事件(AE)。先天免疫,尤其是血管炎症在动脉粥样硬化的发病机理中起作用。 C反应蛋白水平升高的患者肾移植后心血管事件的发生率增加,以及移植后AE和Toll样受体4 Asp299Gly多态性之间的相关性说明了这一点。在这里,我们分析了NOD2 / CARD15基因多态性的影响,因为NOD2可以调节巨噬细胞的促炎活性,并且巨噬细胞存在于早期的动脉粥样硬化病变中。在182 RTR中评估了NOD2基因的三个主要多态性区域(SNP8,SNP12和SNP13)中单核苷酸多态性(SNP)的发生率,并分析了该多态性与AE发生的相关性。肾脏移植后NOD2基因多态性与AE的发生之间没有相关性。因此,NOD2基因多态性似乎并不影响RTR中的心血管并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号